Suchergebnisse - "Yates, James W T"

PubPharm (5)

1

Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent

enthalten in: Journal of medicinal chemistry | 2018

von Foote, K. | Nissink, J. | McGuire, T. | +11

2

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression

enthalten in: Molecular cancer therapeutics | 2018

von Wallez, Y. | Dunlop, C. | Johnson, T. | +7

3

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Ballard, P. | Yates, J. | Yang, Z. | +14

4

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

enthalten in: Molecular cancer therapeutics | 2015

von Guichard, S. | Curwen, J. | Bihani, T. | +15

5

Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yates, J. | Dudley, P. | Cheng, J. | +2

1
[1]